Stanniocalcin 2 Is Upregulated by Calcium-Sensing Receptor and Protects Human Vascular Smooth Muscle Cells from High-Phosphate-Induced Apoptosis

Introduction: Apoptosis of vascular smooth muscle cells induced by hyperphosphatemia is a critical mechanism of chronic kidney disease-related vascular disorders. The present study investigated whether extracellular calcium-sensing receptor (CaSR) regulates stanniocalcin 2 (STC2) expression in HAoSMCs and subsequently protects HAoSMCs from high-phosphate-induced apoptosis. Methods: HAoSMCs were cultured, and STC2 expression was determined by qPCR. A calcimimetic (NPS R-568) or calcilytic (NPS-2143) was applied to HAoSMCs. STC2 mRNA and protein levels were measured by qPCR and Western blot, respectively, and confocal microscopy was employed to investigate subcellular localization. STC2 overexpression and silencing were induced to assess the effects of STC2 on high-phosphate-induced apoptosis, which was determined by caspase-3 levels and TUNEL staining. The anti-apoptotic effect of CaSR-induced STC2 was confirmed by interfering with STC2 expression in the presence of NPS R-568. Results: The constitutive expression of STC2 was confirmed. STC2 mRNA and protein levels were increased by NPS R-568 with or without high phosphate. NPS-2143 resulted in decreased STC2 mRNA levels, but decreased STC2 protein levels were only found under the high-phosphate condition. Confocal microscopy demonstrated the colocalization of STC2 and plasma membrane or endoplasmic reticulum markers. STC2 overexpression reduced HAoSMCs apoptosis, which were reversed with STC2 silencing. NPS R-568 treatment reduced HAoSMCs apoptosis, but STC2 silencing abolished the protective effect. Conclusion: This is the first evidence that STC2 is regulated by CaSR in HAoSMCs. CaSR activation-induced STC2 has putative anti-apoptotic effects against high phosphate. Calcimimetics are promising agents to treat uremic vascular injury.

[1]  K. Tanabe,et al.  Administration of retinoic acid to pregnant mice increases the number of fetal mouse glomeruli , 2022, Biochemistry and biophysics reports.

[2]  Yuh-Feng Lin,et al.  The Effect of PPARγ rs1801282 Variant on Mortality Risk Among Asians With Chronic Kidney Disease: A Cohort Study and Meta-Analysis , 2022, Frontiers in Genetics.

[3]  D. Ward,et al.  Activation of the Calcium Receptor by Calcimimetic Agents Is Preserved Despite Modest Attenuating Effects of Hyperphosphatemia , 2021, Journal of the American Society of Nephrology : JASN.

[4]  T. Akizawa,et al.  Efficacy of Evocalcet in Previously Cinacalcet-Treated Secondary Hyperparathyroidism Patients , 2021, Kidney international reports.

[5]  Dewei Chen,et al.  Stanniocalcin-1 Protected Astrocytes from Hypoxic Damage Through the AMPK Pathway , 2021, Neurochemical Research.

[6]  Nima Abbasian.  Vascular Calcification Mechanisms: Updates and Renewed Insight into Signaling Pathways Involved in High Phosphate-Mediated Vascular Smooth Muscle Cell Calcification , 2021, Biomedicines.

[7]  M. J. Robertson,et al.  Asymmetric activation of the calcium-sensing receptor homodimer , 2021, Nature.

[8]  Lina Yang,et al.  CREBBP knockdown suppressed proliferation and promoted chemo-sensitivity via PERK-mediated unfolded protein response in ovarian cancer , 2021, Journal of Cancer.

[9]  E. V. D. van der Vorst,et al.  Calcium-Sensing Receptor (CaSR), Its Impact on Inflammation and the Consequences on Cardiovascular Health , 2021, International journal of molecular sciences.

[10]  J. Małyszko,et al.  Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation , 2021, Oxidative medicine and cellular longevity.

[11]  V. Schein,et al.  Effects of stanniocalcin hormones on rat hepatic glucose homeostasis under fed and fasted conditions. , 2020, General and comparative endocrinology.

[12]  Wei Cheng,et al.  Stanniocalcin-1 Alleviates Contrast-Induced Acute Kidney Injury by Regulating Mitochondrial Quality Control via the Nrf2 Pathway , 2020, Oxidative medicine and cellular longevity.

[13]  Wei Liu,et al.  Mesenchymal stromal cells ameliorate acute lung injury induced by LPS mainly through stanniocalcin-2 mediating macrophage polarization , 2020, Annals of translational medicine.

[14]  D. Ward,et al.  Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion , 2019, Nature Communications.

[15]  S. Carugo,et al.  The Key Role of Phosphate on Vascular Calcification , 2019, Toxins.

[16]  A. Levy,et al.  Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis. , 2018, Journal of comparative effectiveness research.

[17]  C. Elferink,et al.  Epigenetic Regulation by Agonist-Specific Aryl Hydrocarbon Receptor Recruitment of Metastasis-Associated Protein 2 Selectively Induces Stanniocalcin 2 Expression , 2017, Molecular Pharmacology.

[18]  C. Conover,et al.  Stanniocalcin-2 overexpression reduces atherosclerosis in hypercholesterolemic mice. , 2016, Atherosclerosis.

[19]  Xue Han,et al.  Secreted Frizzled-Related Protein 5 Attenuates High Phosphate-Induced Calcification in Vascular Smooth Muscle Cells by Inhibiting the Wnt/ß-Catenin Pathway , 2016, Calcified Tissue International.

[20]  Z. Massy,et al.  Distinct Effects of Inorganic Phosphate on Cell Cycle and Apoptosis in Human Vascular Smooth Muscle Cells , 2015, Journal of cellular physiology.

[21]  J. Gu,et al.  Activation of gill Ca2+-sensing receptor as a protective pathway to reduce Ca2+-induced cytotoxicity. , 2014, Journal of molecular endocrinology.

[22]  K. Mahaffey,et al.  Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. , 2012, The New England journal of medicine.

[23]  B. Lanske,et al.  Stanniocalcin 2 is associated with ectopic calcification in α-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells. , 2012, Bone.

[24]  C. Wong,et al.  Evolution and roles of stanniocalcin , 2012, Molecular and Cellular Endocrinology.

[25]  M. Chonchol,et al.  The role of phosphorus in the development and progression of vascular calcification. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  G. F. Wagner,et al.  The corpuscles of Stannius, calcium-sensing receptor, and stanniocalcin: responses to calcimimetics and physiological challenges. , 2009, Endocrinology.

[27]  T. Vizard,et al.  Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. , 2009, Cardiovascular research.

[28]  S. Fletcher,et al.  Extracellular Calcium-Sensing Receptor Mediated Signalling is Involved in Human Vascular Smooth Muscle Cell Proliferation and Apoptosis , 2008, Cellular Physiology and Biochemistry.

[29]  A. Fienberg,et al.  Characterization of Stanniocalcin 2, a Novel Target of the Mammalian Unfolded Protein Response with Cytoprotective Properties , 2004, Neurobiology of Aging.

[30]  K. Ishibashi,et al.  Prospect of a stanniocalcin endocrine/paracrine system in mammals. , 2002, American journal of physiology. Renal physiology.